Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.12.106

An inhibitory alternative splice isoform of Toll-like receptor 3 is induced by type I interferons in human astrocyte cell lines  

Seo, Jin-Won (Department of Microbiology, Institute for Immunology and Immunological Diseases, and Brain Korea 21 PLUS Project for Medical Science)
Yang, Eun-Jeong (Department of Microbiology, Institute for Immunology and Immunological Diseases, and Brain Korea 21 PLUS Project for Medical Science)
Kim, Se Hoon (Department of Pathology, Yonsei University College of Medicine, Seoul 03722, Korea)
Choi, In-Hong (Department of Microbiology, Institute for Immunology and Immunological Diseases, and Brain Korea 21 PLUS Project for Medical Science)
Publication Information
BMB Reports / v.48, no.12, 2015 , pp. 696-701 More about this Journal
Abstract
Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA. It stimulates pro-inflammatory cytokine and interferon production. Here we reported the expression of a novel isoform of TLR3 in human astrocyte cell lines whose message is generated by alternative splicing. The isoform represents the N-terminus of the protein. It lacks many of the leucine-rich repeat domains, the transmembrane domain, and the intracellular Toll/interleukin-1 receptor domain of TLR3. Type I interferons (interferon-α and interferon-β) induced the expression of this isoform. Exogenous overexpression of this isoform inhibited interferon regulatory factor 3, signal transducers and activators of transcription 1, and Inhibitor of kappa B α signaling following stimulation. This isoform of TLR3 also inhibited the production of chemokine interferon-γ-inducible protein 10. Our study clearly demonstrated that the expression of this isoform of TLR3 was a negative regulator of signaling pathways and that it was inducible by type I interferons. We also found that this isoform could modulate inflammation in the brain.
Keywords
Astrocyte; Interferon; Isoform; Negative regulation; TLR3;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Matsumoto M, Oshiumi H and Seya T (2011) Antiviral responses induced by the TLR3 pathway. Rev Med Virol 21, 67-77   DOI
2 Hosokawa Y, Hosokawa I, Shindo S, Ozaki K and Matsuo T (2013) TLR3 agonist enhances CC chemokine ligand 20 production in IL-1beta-stimulated human gingival fibroblasts. Cell Immunol 283, 8-11   DOI
3 Yu M and Levine SJ (2011) Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev 22, 63-72   DOI
4 Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F and Meinl E (2005) Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 159, 12-19   DOI
5 Olson JK and Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173, 3916-3924   DOI
6 Matsumoto M, Funami K, Tanabe M et al (2003) Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 171, 3154-3162   DOI
7 Town T, Jeng D, Alexopoulou L, Tan J and Flavell RA (2006) Microglia recognize double-stranded RNA via TLR3. J Immunol 176, 3804-3812   DOI
8 Suh HS, Brosnan CF and Lee SC (2009) Toll-like receptors in CNS viral infections. Curr Top Microbiol Immunol 336, 63-81
9 Galic MA, Riazi K, Henderson AK, Tsutsui S and Pittman QJ (2009) Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36, 343-351   DOI
10 Riazi K, Galic MA and Pittman QJ (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89, 34-42   DOI
11 Dakovic I, da Graca Andrada M, Folha T et al (2014) Clinical features of cerebral palsy in children with symptomatic congenital cytomegalovirus infection. Eur J Paediatr Neurol 18, 618-623   DOI
12 Singh TD, Fugate JE, Hocker SE and Rabinstein AA (2015) Postencephalitic epilepsy: clinical characteristics and predictors. Epilepsia 56, 133-138   DOI
13 Wilson JC, Toovey S, Jick SS and Meier CR (2014) Previously diagnosed influenza infections and the risk of developing epilepsy. Epidemiol Infect, 1-8
14 Sofroniew MV and Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119, 7-35   DOI
15 Le OT, Nguyen TT and Lee SY (2014) Phosphoinositide turnover in Toll-like receptor signaling and trafficking. BMB Rep 47, 361-368   DOI
16 Costello DA and Lynch MA (2013) Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-beta. Hippocampus 23, 696-707   DOI
17 Pan LN, Zhu W, Li Y et al (2014) Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents. PLoS One 9, e99526   DOI
18 Yang E, Shin JS, Kim H et al (2004) Cloning of TLR3 isoform. Yonsei Med J 45, 359-361   DOI
19 Nakajima A, Ibi D, Nagai T, Yamada S, Nabeshima T and Yamada K (2014) Induction of interferon-induced transmembrane protein 3 gene expression by lipopolysaccharide in astrocytes. Eur J Pharmacol 745, 166-175   DOI
20 Kim H, Yang E, Lee J et al (2008) Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology 124, 480-488   DOI
21 Sepulveda FE, Maschalidi S, Colisson R et al (2009) Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737-748   DOI
22 Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6, 823-835   DOI
23 Krieg AM and Vollmer J (2007) Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 220, 251-269   DOI
24 Chockalingam A, Cameron JL, Brooks JC and Leifer CA (2011) Negative regulation of signaling by a soluble form of toll-like receptor 9. Eur J Immunol 41, 2176-2184   DOI
25 Ewald SE, Engel A, Lee J, Wang M, Bogyo M and Barton GM (2011) Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 208, 643-651   DOI
26 Manoury B (2011) TLR9 regulation by proteolysis: a friend or a foe. Eur J Immunol 41, 2142-2144   DOI
27 Garcia-Cattaneo A, Gobert FX, Muller M et al (2012) Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A 109, 9053-9058   DOI
28 Miranda-Hernandez S and Baxter AG (2013) Role of toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol 2, 75-93
29 Touil T, Fitzgerald D, Zhang GX, Rostami A and Gran B (2006) Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 177, 7505-7509   DOI
30 Murakami Y, Fukui R, Motoi Y et al (2014) Roles of the cleaved N-terminal TLR3 fragment and cell surface TLR3 in double-stranded RNA sensing. J Immunol 193, 5208-5217   DOI
31 Toscano F, Estornes Y, Virard F et al (2013) Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol 190, 764-773   DOI
32 Qi R, Singh D and Kao CC (2012) Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization. J Biol Chem 287, 32617-32629   DOI